Small vessel disease lesion type and brain atrophy: The role of co-occurring amyloid
Files
Publication date
2020
Editors
Advisors
Supervisors
Document Type
Article
Metadata
Show full item recordCollections
License
Abstract
Introduction: It is unknown whether different types of small vessel disease (SVD), differentially relate to brain atrophy and if co-occurring Alzheimer's disease pathology affects this relation. Methods: In 725 memory clinic patients with SVD (mean age 67 ± 8 years, 48% female) we compared brain volumes of those with moderate/severe white matter hyperintensities (WMHs; n = 326), lacunes (n = 132) and cerebral microbleeds (n = 321) to a reference group with mild WMHs (n = 197), also considering cerebrospinal fluid (CSF) amyloid status in a subset of patients (n = 488). Results: WMHs and lacunes, but not cerebral microbleeds, were associated with smaller gray matter (GM) volumes. In analyses stratified by CSF amyloid status, WMHs and lacunes were associated with smaller total brain and GM volumes only in amyloid-negative patients. SVD-related atrophy was most evident in frontal (cortical) GM, again predominantly in amyloid-negative patients. Discussion: Amyloid status modifies the differential relation between SVD lesion type and brain atrophy in memory clinic patients.
Keywords
Alzheimer's disease, brain atrophy, cerebral microbleeds, cerebral small vessel disease, lacunes, magnetic resonance imaging, vascular cognitive impairment, white matter hyperintensities, Clinical Neurology, Psychiatry and Mental health, Journal Article
Citation
Heinen, R, Groeneveld, O N, Barkhof, F, de Bresser, J, Exalto, L G, Kuijf, H J, Prins, N D, Scheltens, P, van der Flier, W M, Biessels, G J & TRACE‐VCI study group 2020, 'Small vessel disease lesion type and brain atrophy : The role of co-occurring amyloid', Alzheimer's and Dementia: Diagnosis, Assessment and Disease Monitoring, vol. 12, no. 1, e12060, pp. 1-11. https://doi.org/10.1002/dad2.12060